IRCT201407018323N11已完成未知
The evaluation of the Effect of Fingolimod on Fatigue and depression in patients with Multiple Sclerosis
Deputy of Research and Technology of Kermanshah University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 50 years（—）
- 性别
- All
入选标准
- •Inclusion Criteria: age 18-50 years; definite M.S confirmed by neurologist with relapsing remitting type; disease must be in remission; at least one month after corticostroid therapy; follow up shouldbe possible and patients must be reachable. exclusion criteria: any underlying pulmonary,hepatic,renal or orthopedic; EDSS score>5.5; during follow up events that affect depression happen to the patients.
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Evaluating the efficacy and side effects fingolimod in 3 -year follow-up of patients with recurrent forms of multiple sclerosisIRCT201705108323N15Vice chancellor for research, Kermanshah University of Medical Sciences50
尚未招募
不适用
Study of absorption and elimination rate of Fingolimod 0.5-mg capsule in comparison with Fingolimod brand Capsule (Gilenya®).Bioequivalence study.IRCT20200407046981N26Zahravi pharmaceutical company24
已完成
不适用
comparison of Fingolimode and Betaferon(high dose) in M.S treatmentMultiple SclerosisIRCT2015112025146N1Isfahan University of Medical Sciences50
招募中
Unknown
Bioequivalence study of Fingolimod 0.5 mg capsuleIRCT20200105046010N92Abidi Company24
招募中
不适用
The efficacy and tolerability of modafinil for fatigue and daytime sleepiness in cancer patients: preliminary studyKCT0001412Seoul National University Bundang Hospital20